These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26526778)

  • 1. [Malignant hypertension and cardiac decompensation after overuse of nasal decongestant: A case report and literature review].
    Novais T; Bourdelin M; Le Vavasseur O; Bontemps H
    Rev Med Interne; 2016 Jun; 37(6):424-8. PubMed ID: 26526778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhagic stroke after naphazoline exposition: case report.
    Zavala JA; Pereira ER; Zétola VH; Teive HA; Nóvak EM; Werneck LC
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):889-91. PubMed ID: 15476091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphazoline intoxication in a child-a clinical and forensic toxicological case.
    Musshoff F; Gerschlauer A; Madea B
    Forensic Sci Int; 2003 Jul; 134(2-3):234-7. PubMed ID: 12850424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive crisis from chronic intoxication with nasal decongestant and cough medications.
    Heyman SN; Mevorach D; Ghanem J
    DICP; 1991 Oct; 25(10):1068-70. PubMed ID: 1725079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on nasal mucosa injury and repair induced by nasal decongestants in guinea pigs].
    Wang YN; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 53(6):432-439. PubMed ID: 29902847
    [No Abstract]   [Full Text] [Related]  

  • 6. Is it a hypertensive crisis?
    Rubenzahl SE
    Can Fam Physician; 1993 May; 39():1024. PubMed ID: 7684631
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial hypertension induced by a nasal decongestant. Value of the use of an automatic and programmable recording technic].
    Balansard P; Mathieu F; Normand P; Frances Y; Luccioni R
    Sem Hop; 1983 Dec; 59(44):3059-61. PubMed ID: 6198723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic stroke in a man with naphazoline abuse history.
    Costantino G; Ceriani E; Sandrone G; Montano N
    Am J Emerg Med; 2007 Oct; 25(8):983.e1-2. PubMed ID: 17920988
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report: unilateral mydriasis from topical Opcon-A and soft contact lens.
    Williams TL; Williams AJ; Enzenauer RW
    Aviat Space Environ Med; 1997 Nov; 68(11):1035-7. PubMed ID: 9383505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal decongestant and chronic headache: a case of naphazoline overuse headache?
    Di Lorenzo C; Coppola G; La Salvia V; Pierelli F
    F1000Res; 2013; 2():237. PubMed ID: 25110575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe poisoning with naphazoline: update from a therapeutic error].
    Díaz M; Granson E; Taiman J; Alava J; Gabrielli T; Mendoza L
    Arch Argent Pediatr; 2018 Aug; 116(4):e626-e629. PubMed ID: 30016045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use.
    Liguori C; Garaci F; Romigi A; Mercuri NB; Marciani MG; Placidi F
    Neurol Sci; 2015 Jul; 36(7):1285-6. PubMed ID: 25527367
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants.
    Soparkar CN; Wilhelmus KR; Koch DD; Wallace GW; Jones DB
    Arch Ophthalmol; 1997 Jan; 115(1):34-8. PubMed ID: 9006422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Danger of nasal vasoconstrictors in infants. Apropos of a case].
    Claudet I; Fries F
    Arch Pediatr; 1997 Jun; 4(6):538-41. PubMed ID: 9239269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary edema and prolonged awakening after nasal naphazoline application in a transspenoidal hypophysectomy patient.
    Klein KU; Wisser G; Engelhard K; Werner C
    J Neurosurg Anesthesiol; 2010 Jul; 22(3):269. PubMed ID: 20548172
    [No Abstract]   [Full Text] [Related]  

  • 19. Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study.
    Perrin S; Montani D; O'Connell C; Günther S; Girerd B; Savale L; Guignabert C; Sitbon O; Simonneau G; Humbert M; Chaumais MC
    Eur Respir J; 2015 Oct; 46(4):1211-4. PubMed ID: 26206880
    [No Abstract]   [Full Text] [Related]  

  • 20. Bilateral acute angle-closure glaucoma after use of Fenox nasal drops.
    Khan MA; Watt LL; Hugkulstone CE
    Eye (Lond); 2002 Sep; 16(5):662-3. PubMed ID: 12194094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.